April 21, 2009
Global leader in assay technology improves speed and sensitivity for detection of proteins associated with diseases Experimental Biology 2009 NEW ORLEANS--At Experimental Biology 2009, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of Western BLAST™, an amplification system used to enhance and simplify [...]
VIASPACE Inc. to Demonstrate New Technology for Chemical, Explosive and Drug Detection
April 21, 2009
Under $786,000 Phase II Contract with U.S. Navy PASADENA, Calif., April 21 -- VIASPACE Inc. (OTC Bulletin Board: VSPC) an alternative energy company with subsidiary operations in security technology, is planning a mid-May 2009 field demonstration of its high-sensitivity system for detecting and analyzing chemical, explosive, and drug residues in suspect vessels. The demonstration is [...]
April 21, 2009
CARLSBAD, Calif.--Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), today unveiled new approaches for using next-generation genomic analysis sequencing to better understand methylation patterns in different cancerous disease states. A team of research and development scientists utilized the SOLiD™ System, an advanced genomic analysis technology, to characterize the methylation status of repetitive elements in [...]
Oscar-Werner Reif Becomes New Member of The Board of Sartorius Stedim Biotech S.A.
April 21, 2009
Annual General Shareholders’ Meeting appoints R&D Vice President to the top executive committee AUBAGNE, France & GOETTINGEN, Germany--The Annual General Shareholders’ Meeting of Sartorius Stedim Biotech S.A. (Paris:DIM) listed on the French stock exchange resolved today to appoint Dr. Oscar-Werner Reif as an additional member to the Board of Directors. By passing this resolution, the [...]
Symyx Expands Biologics Advisory Board
April 21, 2009
Industry Advisory Group for Biologics Representation, Registration, and Management Extends Invitation for Additional Board Members SUNNYVALE, CA--Apr 21, 2009 -- Over the next five years, the market for biologically based drugs, or biologics, is expected to grow much faster than the market for traditional small molecule-derived drugs. Biologics represent an increasing proportion of pharmaceutical company [...]
Arrayit Speeds Analysis of the Human Genome
April 21, 2009
SUNNYVALE, CA--Apr 21, 2009 -- Arrayit Corporation (OTC BB:ARYC.OB - News), a life sciences and healthcare technology leader, announces a scientific breakthrough that accelerates the analysis of the human genome. The scientific discovery by Arrayit scientists, which combines advances in surface chemistry, bioinformatics, instrumentation and microarray technology, reduces the time required to analyze the human [...]
NuGEN Expands Product Portfolio with New Applause™ Brand RNA Amplification Products
April 21, 2009
Solution Complements Established Small Sample Capabilities to Now Address Virtually All Sample Types SAN CARLOS, Calif.--NuGEN Technologies, Inc., a leader in nucleic acid amplification and sample preparation, announced today that it has employed its powerful, Single Primer Isothermal Amplification (SPIA®) technology to create a new line of products that offers life scientists a fast, simple, [...]
Fluxion Biosciences Completes European Network with New Distributor for Italy and Spain
April 21, 2009
EuroClone S.p.A. to Distribute BioFlux™ Line of Live Cell Imaging Products San Francisco, Calif. (April 21, 2009) – Fluxion Biosciences announced today an exclusive distribution agreement with EuroClone S.p.A., headquartered in Milan, Italy. EuroClone will handle sales and service of Fluxion’s BioFlux research tools for live cell image analysis in Italy, Spain and Portugal as [...]
April 21, 2009
NEW YORK, April 21 -- GenVault, a leading provider of room-temperature biosample transport, storage and management technologies, announced the release today of GenConnect 3.2, the newest version of its software for complete biosample management. Highlights of the release include a strategic licensing model that enables GenConnect to be integrated seamlessly into third-party informatics offerings, as [...]
Roche NimbleGen and Sigma-Aldrich Collaborate to Advance Epigenetic Research
April 21, 2009
MADISON, Wis. & ST. LOUIS--Roche NimbleGen and Sigma-Aldrich (Nasdaq:SIAL) have started a collaboration to further chromatin immunoprecipitation-on-microarray (ChIP-chip) research by aligning their two complementary technologies, Roche NimbleGen’s ChIP-chip high-density microarrays and GenomePlex by Sigma-Aldrich. Together, the platforms enable researchers to effectively study the entire genome for epigenetic interactions between DNA and DNA-binding proteins to determine [...]

